- TraceLink is the world's largest track and trace network for the life sciences supply chain, focused on eliminating counterfeit prescription drugs and enhancing supply chain orchestration.
- In February 2026, TraceLink outlined its strategic priorities for scaling agentic orchestration and highlighted the successful execution of the U.S. Drug Supply Chain Security Act (DSCSA) in 2025, activating approximately 300 new DSCSA live links per week.
- The company serves over 310,000 customers and trading partners, including major pharmaceutical manufacturers and distributors, leveraging its OPUS platform to enhance supply chain efficiency and compliance.
- TraceLink's ideal buyers are pharmaceutical manufacturers and distributors looking to improve supply chain security and operational efficiency, particularly in light of increasing regulatory complexities and the need for digital transformation.
TraceLink's workforce is organized into 14 departments, with Engineering (69 employees) and Information Technology (67 employees) representing the largest segments. Operations follows with a headcount of 42, indicating a robust technical and operational foundation. The distribution across departments reflects a balanced approach to software development, ensuring that both technical and operational needs are met effectively.
The company's workforce is spread across 34 locations, with North Reading, MA (62 employees) and Woburn, MA (45 employees) being the largest hubs. Wilmington, MA contributes 17 employees, while the 'Other' category, accounting for 208 employees, suggests a significant remote or distributed workforce. This geographic distribution highlights a concentration in Massachusetts, while also indicating a flexible approach to location strategy.
